Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Gelmon, Karen"'
Autor:
Chapman JW; Canadian Cancer Trials Group Queen's University, Kitchener, Canada., Bayani J; Ontario Institute for Cancer Research, Toronto, Canada.; University of Toronto, Toronto, Canada., SenGupta S; Queen's University, Kingston, Canada., Bartlett JMS; University of Edinburgh, Edinburgh, United Kingdom., Piper T; University of Edinburgh, Edinburgh, United Kingdom., Quintayo MA; Ontario Institute for Cancer Research, Toronto, Canada., Virk S; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Goss PE; Harvard University, Boston, MA., Ingle JN; Harvard University, Boston, MA., Ellis MJ; Progendis, Gaithersburg, MD., Sledge GW; Caris Life Sciences, Irving, TX., Budd GT; Cleveland Clinic, Cleveland, OH., Rabaglio M; Inselspital Bern, Bern, Switzerland., Ansari RH; Indiana School of Medicine, South Bend, IN., Tozer R; McMaster University, Hamilton, Canada., D'Souza DP; London Regional Health Science Centre, London, Canada., Chalchal H; Alan Blair Cancer Center, Regina, Canada., Spadafora S; Algoma Regional Cancer Centre, Sault Ste Marie, Canada., Stearns V; Weill Cornell Medicine, New York, NY., Perez EA; Harvard University, Boston, MA.; Mayo Clinic, Redwood City, CA., Gelmon KA; University of British Columbia, Vancouver, Canada., Whelan TJ; McMaster University, Hamilton, Canada., Elliott C; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Shepherd LE; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Chen BE; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Taylor KJ; University of Edinburgh, Edinburgh, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 20; Vol. 42 (24), pp. 2887-2898. Date of Electronic Publication: 2024 Jun 02.
Autor:
LeVasseur N; Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada., Sun J; Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada., Fenton D; Vancouver Island Centre, British Columbia, V8R 1J8, Canada., Baxter S; Sindi Ahluwalia Hawkins Centre for the Southern Interior, Kelowna, British Columbia, V1Y 5L3, Canada., Chan A; Fraser Valley Centre, Surrey, British Columbia, V3V 1Z2, Canada., Roberts S; Center for the North, Prince George, British Columbia, V2M 7E9, Canada., Feng X; Vancouver Island Centre, British Columbia, V8R 1J8, Canada., Lohrisch C; Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada., Gelmon K; Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada., Shenkier T; Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada., Chia SK; Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada. Electronic address: schia@bccancer.bc.ca.
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2022 Jan; Vol. 22 (1), pp. e74-e79. Date of Electronic Publication: 2021 Sep 17.
Autor:
Gelmon K; British Columbia Cancer Agency, Vancouver, BC, Canada. Electronic address: kgelmon@bccancer.bc.ca., Walshe JM; Cancer Trials Ireland, Dublin, Ireland., Mahtani R; Sylvester Cancer Center, University of Miami, Deerfield Beach, FL, USA., Joy AA; Cross Cancer Institute, Edmonton, AB, Canada., Karuturi M; MD Anderson Cancer Center, Houston, TX, USA., Neven P; Breast Centre, UZ Leuven, Leuven, Belgium., Lu DR; Pfizer Inc, San Diego, CA, USA., Kim S; Pfizer Inc, San Diego, CA, USA., Schnell P; Pfizer Inc, New York, NY, USA., Bananis E; Pfizer Inc, New York, NY, USA., Schwartzberg L; West Cancer Center, Germantown, TN, USA.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2021 Oct; Vol. 59, pp. 321-326. Date of Electronic Publication: 2021 Jul 28.
Autor:
Loibl S; German Breast Group, Neu-Isenburg, Germany.; Center for Hematology and Oncology Bethanien, Frankfurt, Germany., Marmé F; Department of Gynaecology and Obstetrics, University Hospital Mannheim, Mannheim, Germany., Martin M; Instituto de Investigacion Sanitaria Gregorio Marañon, CIBERONC, Universidad Complutense, Madrid, Spain.; GEICAM, Madrid, Spain., Untch M; Department of Gynaecology and Obstetrics, Breast Cancer Center, HELIOS Klinikum Berlin Buch, Berlin, Germany., Bonnefoi H; UCBG (Unicancer Breast Cancer Group) and Institut Bergonié, Université de Bordeaux, Bordeaux, France., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, and KCSG (Korean Cancer Study Group), Korea., Bear H; Division of Surgical Oncology, Massey Cancer Center, Virginia Commonwealth University, VCU Health, Richmond, VA.; NSABP Foundation, Pittsburgh, PA., McCarthy N; Breast Cancer Trials Australia and New Zealand, Newcastle, Australia., Melé Olivé M; GEICAM, Madrid, Spain.; Oncology Research Group, Hospital Universitario Sant Joan de Reus, Reus, Spain., Gelmon K; BC Cancer Agency, Vancouver, British Columbia, Canada., García-Sáenz J; GEICAM, Madrid, Spain.; Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain., Kelly CM; Mater Misericordiae University Hospital and Breast Group, Cancer Trials, Dublin, Ireland., Reimer T; Department of Obstetrics and Gynecology, University of Rostock, Rostock, Germany., Toi M; Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Rugo HS; Breast Department, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA., Denkert C; German Breast Group, Neu-Isenburg, Germany.; Institute of Pathology, University Hospital Marburg and Philipps-Universität Marburg, Germany., Gnant M; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; ABCSG, Vienna, Austria., Makris A; Mount Vernon Cancer Centre, Northwood, United Kingdom., Koehler M; Pfizer Inc, New York, NY., Huang-Bartelett C; Pfizer Inc, New York, NY., Lechuga Frean MJ; Pfizer Inc, New York, NY., Colleoni M; IEO, European Institute of Oncology, IRCCS, Milan, Italy., Werutsky G; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., Seiler S; German Breast Group, Neu-Isenburg, Germany., Burchardi N; German Breast Group, Neu-Isenburg, Germany., Nekljudova V; German Breast Group, Neu-Isenburg, Germany., von Minckwitz G; German Breast Group, Neu-Isenburg, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 May 10; Vol. 39 (14), pp. 1518-1530. Date of Electronic Publication: 2021 Apr 01.
Autor:
Finn RS; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, California. RFinn@mednet.ucla.edu., Liu Y; Pfizer Inc, Global Product Development Oncology, La Jolla, California., Zhu Z; Pfizer Inc, Oncology Translational Research/Computational Biology, La Jolla, California., Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, Ciberonc, Universidad Complutense, Madrid, Spain., Rugo HS; Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Diéras V; Department of Breast Oncology, Institut Curie, and Centre Eugène Marquis, Rennes, France., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Gelmon KA; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Harbeck N; Department of OB&GYN, Brustzentrum der Universität München (LMU), München, Germany., Lu DR; Pfizer Inc, Clinical Statistics, La Jolla, California., Gauthier E; Pfizer Inc, Department of Clinical Research, San Francisco, California., Huang Bartlett C; Pfizer Inc, Global Medical Affairs, Collegeville, Pennsylvania., Slamon DJ; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jan 01; Vol. 26 (1), pp. 110-121. Date of Electronic Publication: 2019 Sep 16.
Autor:
Diéras V; Institut Curie, Paris, France (VD)., Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA (HSR)., Schnell P; Pfizer Inc, Collegeville, PA (PS, CHB)., Gelmon K; British Columbia Cancer Agency, Vancouver, BC, Canada (KG)., Cristofanilli M; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, IL (MC)., Loi S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (SL)., Colleoni M; Istituto Europeo di Oncologia, Milan, Italy (MC)., Lu DR; Pfizer Inc, La Jolla, CA (DRL)., Mori A; Pfizer Inc, Milano, Italy (AM)., Gauthier E; Pfizer Inc, San Francisco, CA (EG)., Huang Bartlett C; Pfizer Inc, Collegeville, PA (PS, CHB)., Slamon DJ; David Geffen School of Medicine, Los Angeles, CA (DJS, RSF)., Turner NC; Institute of Cancer Research and Royal Marsden Hospital, London, UK (NCT)., Finn RS; David Geffen School of Medicine, Los Angeles, CA (DJS, RSF).
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2019 Apr 01; Vol. 111 (4), pp. 419-430.
Autor:
Drögemöller BI; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada., Wright GEB; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Shih J; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada., Monzon JG; Tom Baker Cancer Centre, Calgary, AB, Canada., Gelmon KA; BC Cancer Agency and University of British Columbia, Vancouver, BC, Canada., Ross CJD; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Amstutz U; University Institute of Clinical Chemistry, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland., Carleton BC; BC Children's Hospital Research Institute, Vancouver, BC, Canada. bcarleton@popi.ubc.ca.; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. bcarleton@popi.ubc.ca.; Pharmaceutical Outcomes Programme, BC Children's Hospital Research Institute, 950 West 28th Ave, Vancouver, BC, V5Z 4H4, Canada. bcarleton@popi.ubc.ca.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2019 Feb; Vol. 173 (3), pp. 521-532. Date of Electronic Publication: 2018 Nov 08.
Autor:
Chapman JA, Nielsen TO, Ellis MJ, Bernard P, Chia S, Gelmon KA, Pritchard KI, Le Maitre A, Goss PE, Leung S, Shepherd LE, Bramwell VH
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2013; Vol. 15 (4), pp. R71.
Autor:
Kennecke H; Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. hkennecke@bccancer.bc.ca, McArthur H, Olivotto IA, Speers C, Bajdik C, Chia SK, Ellard S, Norris B, Hayes M, Barnett J, Gelmon KA
Publikováno v:
Cancer [Cancer] 2008 Apr 01; Vol. 112 (7), pp. 1437-44.
Autor:
Yerushalmi R; British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 4E6., Gelmon K
Publikováno v:
Lancet (London, England) [Lancet] 2008 Jan 05; Vol. 371 (9606), pp. 4-5.